Ann Thorac Surg 1996;62:1730
© 1996 The Society of Thoracic Surgeons
Discussion
Discussion
| The first 20% of the full text of this article appears below. |
see also page 1724.
DR YARON BAR-EL (Haifa, Israel): I congratulate Dr Gabbay and his group for this excellent research and presentation. After a careful review of the preclinical data, we at the Rambam Medical Center in Israel have joined a few European and South American clinical centers to investigate the No-React bioprosthesis. We have been using the No-React bioprosthesis for the past year and have implanted various kinds of grafts in 8 patients. We have implanted two stentless mitral valves, five aortic stentless valves, one porcine internal mammary artery graft, and one femoropopliteal bypass below-knee graft using a bovine internal mammary artery graft. I would like to draw your attention to 2 patients who were youngsters, aged 12 and 13 years, at the time of operation.
The first is a girl who was flown in emergently with active bacterial endocarditis that destroyed her mitral . . . [Full Text of this Article]
Related Article
-
No-React Detoxification Process: A Superior Anticalcification Method for Bioprostheses
- Amir Abolhoda, Sumei Yu, J. Rodrigo Oyarzun, Keith R. Allen, John R. McCormick, Shenggao Han, Francis W. Kemp, John D. Bogden, Qi Lu, and Shlomo Gabbay
Ann. Thorac. Surg. 1996 62: 1724-1730.
[Abstract]
[Full Text]
Copyright © 1996 by The Society of Thoracic Surgeons.